FDA is finally acting to restrict asthma drugs that have been known to cause asthma
The U.S. Food and Drug Administration (FDA) recently issued new restrictions for four popular long-acting asthma drugs.
Novartis AG's Foradil, GlaxoSmithKline's Serevent and Advair, and AstraZeneca's Symbicort, all contain an ingredient that relaxes airway muscles in the lungs
which can cause asthma-related death.
If not accompanied by other asthma drugs to offset this life-threatening side effect, the consequences could be fatal. These drugs have long contained a label that reads, "increases risk of asthma-related death", but apparently this warning is not enough for this extreme class of medications.
Known as long-acting beta-agonists (LABAs), these asthma drugs are used by roughly six million asthma sufferers to combat asthma symptoms.
Ironically, LABAs are so dangerous that, if not combined with other asthma drugs, can actually cause an asthma attack.
FDA: Tougher Warnings for some Asthma Drugs | InjuryBoard Houston
FDA: Long-Acting Asthma Drugs Increase Asthma Risks - WSJ.com
Please register to participate in our discussions with 2 million other members - it's free and quick! Some forums can only be seen by registered members. After you create your account, you'll be able to customize options and access all our 15,000 new posts/day with fewer ads.
